Abstract Search

ea0035p364 | Diabetes (epidemiology, pathophysiology) | ECE2014

Does systematic error in the HbA1c measurement matter when locally analyzed HbA1c is used for benchmarking in a national diabetes register?

Carlsen Siri , Cooper John , Thue Geir , Roraas Thomas , Lovas Karianne , Goransson Lasse , Sandberg Sverre

Introduction: HbA1c is an important quality indicator when benchmarking diabetes clinics. Systematic error in the measurement of HbA1c could result in inappropriately high or low values, and if not corrected give a wrong impression of the standard of care.Methods: We included data on HbA1c from the Norwegian adult diabetes register on 3,854 type 1 diabetics attending 13 hospital clinics. Correction factors for HbA1c were derived from the results of the l...

0 shares

ea0035p876 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Preoperative octreotide treatment of acromegaly: long-term results of a randomized, controlled study

Fougner Stine Lyngvi , Bollerslev Jens , Svartberg Johan , Oksnes Marianne , Cooper John , Carlsen Sven M

Objective: Early postoperative results for the Preoperative Octreotide Treatment of Acromegaly (POTA) study has been published, and like later randomized studies we demonstrated a beneficial effect of presurgical treatment with somatostatin analogues (SSA) in GH-secreting macroadenomas when evaluated 34 months postoperatively. However, concerns about a potential lingering effect of SSA and thereby potential false positive results have been raised. The objective of this s...

0 shares

ePoster

Endocrine Abstracts

Does systematic error in the HbA1c measurement matter when locally analyzed HbA1c is used for benchmarking in a national diabetes register?

Preoperative octreotide treatment of acromegaly: long-term results of a randomized, controlled study

BiosciAbstracts